Literature DB >> 15615770

Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis.

Cathie Garnis1, Jennifer Campbell, Jonathan J Davies, Calum Macaulay, Stephen Lam, Wan L Lam.   

Abstract

Lung cancer is the leading cause of cancer death in North America. Despite advances in lung cancer treatment, the overall 5 year survival rate for those diagnosed with the disease is bleak presumably due to the late stage of diagnosis. Owing to the difficulty of early detection, preneoplastic specimens are rare. However, studying both preinvasive and invasive stages of disease is necessary to fully understand lung cancer progression. Aberration of chromosome arm 1p is common in lung and other cancers. In this study, we used a genomic array with complete tiling coverage of 1p to profile preinvasive and invasive squamous non-small cell lung carcinoma samples. With this technology, multiple novel submegabase alterations were identified. Three of the 1p alterations harbored genes belonging to gene families known to be involved in cancer development through either the Wnt or the Notch developmental pathways. Our finding of a 0.4 Mb amplified region at 1p36.12 containing WNT4 in preinvasive lung cancer, coupled with the identification of three additional alterations in invasive tumors that also contain genes related to the Notch and Wnt pathways, strongly suggests an intricate role of these pathways in early and late stages of lung cancer development. Furthermore, ectopic expression of DVL1, LRP8 and Notch2 in malignant lung tissue validates the biological impact of these genetic alterations. Importantly, this implication of pathways known only to be activated in fetal lung development lends support to the proposed model of lung cancer ontology whereby tumors arise from dysregulated pleuripotent stem cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615770     DOI: 10.1093/hmg/ddi043

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

1.  Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.

Authors:  Jake Higgins; Michele Brogley; Nallasivam Palanisamy; Rohit Mehra; Michael M Ittmann; Jun Z Li; Scott A Tomlins; Diane M Robins
Journal:  Horm Cancer       Date:  2015-01-29       Impact factor: 3.869

2.  Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML.

Authors:  Ana Rosa S Costa; Sintia I Belangero; Maria Isabel Melaragno; Maria de Lourdes Chauffaille
Journal:  Med Oncol       Date:  2011-11-25       Impact factor: 3.064

3.  Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines.

Authors:  Chunyan Li; Ying Zhang; Yao Lu; Zeshi Cui; Miao Yu; Siyang Zhang; Xiaoxia Xue
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-08       Impact factor: 4.553

4.  Macrophage migration inhibitory factor: a central regulator of wound healing.

Authors:  Matthew J Hardman; Alexander Waite; Leo Zeef; Matthew Burow; Toshinori Nakayama; Gillian S Ashcroft
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 5.  Guidance molecules in lung cancer.

Authors:  Patrick Nasarre; Vincent Potiron; Harry Drabkin; Joëlle Roche
Journal:  Cell Adh Migr       Date:  2010-01-07       Impact factor: 3.405

6.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

7.  Array CGH reveals genomic aberrations in human emphysema.

Authors:  Jin Soo Choi; Woon Jeong Lee; Seung Ho Baik; Hyoung Kyu Yoon; Kweon-Haeng Lee; Yeul Hong Kim; Young Lim; Young-Pil Wang
Journal:  Lung       Date:  2009-04-08       Impact factor: 2.584

8.  Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer.

Authors:  Antoinette S Perry; Gillian O'Hurley; Omer A Raheem; Kevin Brennan; Simon Wong; Anthony O'Grady; Anne-Marie Kennedy; Laure Marignol; Therese M Murphy; Linda Sullivan; Ciara Barrett; Barbara Loftus; John Thornhill; Stephen M Hewitt; Mark Lawler; Elaine Kay; Thomas Lynch; Donal Hollywood
Journal:  Int J Cancer       Date:  2012-09-28       Impact factor: 7.396

9.  Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.

Authors:  Chang-Ching Lin; Miao-Chia Lo; Rebecca Moody; Hui Jiang; Ramdane Harouaka; Nicholas Stevers; Samantha Tinsley; Mari Gasparyan; Max Wicha; Duxin Sun
Journal:  Cancer Lett       Date:  2018-09-15       Impact factor: 8.679

10.  Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.

Authors:  Frank McCaughan; Jessica C M Pole; Alan T Bankier; Bernard A Konfortov; Bernadette Carroll; Mary Falzon; Terence H Rabbitts; P Jeremy George; Paul H Dear; Pamela H Rabbitts
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.